Quest for the right Drug
רופיוקאין פרזניוס 2מג'/מל' תמיסה לעירוי ROPIVACAINE FRESENIUS 2 MG/ML SOLUTION FOR INFUSION (ROPIVACAINE HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
לסביבת העצב, אפידורל : PERINEURAL, EPIDURAL
צורת מינון:
תמיסה לאינפוזיה : SOLUTION FOR INFUSION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects General The adverse reaction profile for Ropivacaine is similar to those for other long acting local anaesthetics of the amide type. Adverse reactions should be distinguished from the physiological effects of the nerve block itself e.g. Hypotension (a decrease in blood pressure), bradycardia during spinal/ epidural block. Table of adverse reactions The following frequencies are used for the description of the occurrence of adverse reactions: very common (1/10), common (1/100 to <1/10), uncommon (1/1,000 to <1/100), rare (1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data ). System organ class Frequency Undesirable effects Immune system disorder Rare Allergic reactions (anaphylactic reactions , angioneurotic oedema and urticaria Psychiatric Disorders Uncommon Anxiety Nervous System Disorders Common Paraesthesia, dizziness, headache Uncommon Symptoms of CNS toxicity (convulsions, grand mal convulsions, seizures, light headedness, circumoral paraesthesia, numbness of the tongue, hyperacusis, tinnitus, visual disturbances, dysarthria, muscular twitching, tremor)*, hypoaesthesia Not known Dyskinesia Cardiac Disorders Common Bradycardia, tachycardia Rare Cardiac arrest, cardiac arrhythmias Vascular Disorders Very common Hypotension Common Hypertension Dyskinesia Uncommon Syncope Respiratory, Thoracic and Uncommon Dyspnoea Mediastinal Disorders Dyskinesia Gastrointestinal Disorders Very common Nausea Common Vomiting Musculoskeletal and Common back pain Connective tissue disorders Renal and Urinary Common Urinary retention Disorders General Disorders and Common Temperature elevation, Administration Site Chills Conditions Uncommon Hypothermia * These symptoms usually occur because of inadvertent intravascular injection, overdose or rapid absorption, see section 4.9. Class-related adverse reactions Neurological complications Neuropathy and spinal cord dysfunction (e.g. anterior spinal artery syndrome, arachnoiditis, cauda equina), which may result in rare cases of permanent sequelae, have been associated with regional anaesthesia, regardless of the local anaesthetic used. Total spinal block Total spinal block may occur if an epidural dose is inadvertently administered intrathecally. Acute systemic toxicity Systemic toxic reactions primarily involve the central nervous system (CNS) and the cardiovascular system (CVS). Such reactions are caused by high blood concentration of a local anaesthetic, which may appear due to (accidental) intravascular injection, overdose or exceptionally rapid absorption from highly vascularized areas, see also section 4.4. CNS reactions are similar for all amide local anaesthetics, while cardiac reactions are more dependent on the drugs, both quantitatively and qualitatively. Central nervous system toxicity Central nervous system toxicity is a graded response with symptoms and signs of escalating severity. Initially symptoms such as visual or hearing disturbances, perioral numbness, diziness, light-headedness, tingaling and paraesthesia are seen. Dysarthria, muscular rigidity and muscular twitching are more serious and may precede the onset of generalised convulsions. These signs must not be mistaken for neurotic behaviour. Unconsciousness and grand mal convulsions may follow, which may last from a few seconds to several minutes. Hypoxia and hypercarbia occur rapidly during convulsions due to the increased muscular activity, together with the interference with respiration. In severe cases even apnoea may occur. The respiratory and metabolic acidosis increases and extends the toxic effects of local anaesthetics. Recovery follows the redistribution of the local anaesthetic from the central nervous system and subsequent metabolism and excretion. Recovery may be rapid unless large amounts of the active substance have been injected. Cardiovascular system toxicity Cardiovascular toxicity indicates a more severe situation. Hypotension, bradycardia, arrhythmia and even cardiac arrest may occur as a result of high systemic concentrations of local anaesthetics. In volunteers the intravenous infusion of ropivacaine resulted in signs of depression of conductivity and contractility. Cardiovascular toxic effects are generally preceded by signs of toxicity in the central nervous system, unless the patient is receiving a general anaesthetic or is heavily sedated with drugs such as benzodiazepines or barbiturates. Treatment of acute systemic toxicity (See section 4.9) Reporting of suspected adverse reactions Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il /and emailed to the Registration Holder’s Patient Safety Unit at: drugsafety@neopharmgroup.com.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף